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Summary
Borrelia burgdorferi is an obligate parasite with a
limited genome that severely narrows its metabolic
and biosynthetic capabilities. Thus survival of this
spirochaete in an arthropod vector and mammalian
host requires that it can scavenge amino acids, fatty
acids and nucleosides from a blood meal or various
host tissues. Additionally, the utilization of ribonucle-
otides for DNAsynthesis is further complicated by the
lack of a ribonucleotide reductase for the conversion
of nucleoside-5-diphosphates to deoxynucleosides-
5-diphosphates. The data presented here demon-
strate that B. burgdorferi must rely on host-derived
sources of purine bases, deoxypurines and deoxypy-
rimidines for the synthesis of DNA. However, if deox-
yguanosine (dGuo) is limited in host tissue, the
enzymatic activities of a 2-deoxyribosyltransferase
(DRTase, encoded by bb0426), IMP dehydrogenase
(GuaB) and GMP synthase (GuaA) catalyse the multi-
step conversion of hypoxanthine (Hyp) to dGMP for
DNA synthesis. This pathway provides additional bio-
chemicalﬂexibilityforB. burgdorferiwhenitcolonizes
and infects different host tissues.
Introduction
The synthesis of nucleic acids is critical in all living organ-
isms as a means of storing and processing information for
all cellular functions. Likewise, the production and/or
assimilationofpurineandpyrimidinebasesfornucleicacid
synthesis are also essential. Organisms with complete
purine and pyrimidine biosynthetic pathways are capable
of producing nucleotides de novo and do not require an
external source of nucleic acid intermediates. Conversely,
some pathogenic bacteria lack a complete set of functional
enzymestocatalysenucleotidesynthesisandmustrelyon
salvage pathways that require host-derived sources of
nucleotide precursors (Nygaard, 1993). Such obligate
parasites must generally have, at minimum, a core set of
essential enzymes to perform basic purine/pyrimidine
salvage metabolism.Acritical enzyme in either de novo or
salvage pathways is the ribonucleotide reductase (RNR),
which enzymatically reduces ribonucleotides to their
deoxy-analogues and maintains an adequate deoxynucle-
otide pool, through allosteric regulation, for efficient incor-
poration into DNA. It is widely thought that these enzymes
are central to even the most basic nucleotide pathway and
critical for all living organisms, regardless of their capabili-
ties for purine/pyrimidine biosynthesis (Nordlund and Rei-
chard, 2006).
Borrelia burgdorferi, the etiological agent of Lyme
disease, is an obligate parasite with a 1.5-mega-base
genome (Fraser et al., 1997), and limited metabolic and
biosynthetic capacity. Survival in its arthropod vector and
mammalian host requires the organism to ‘scavenge’
amino acids, fatty acids and nucleosides for the biosyn-
thesis of proteins, lipids/lipoproteins and nucleic acids
respectively. The success of this bacterium is also depen-
dent upon making efficient use of ribonucleotides for DNA
synthesis in the absence of a functional RNR. This deﬁ-
ciency limits the biochemical options for DNA synthesis in
B. burgdorferi to either acquiring all deoxynucleosides
from the host, potentially limiting the available sites for
host colonization and replication (e.g. Ureaplasma ure-
alyticum) (Carnrot et al., 2003) and/or biochemically
modifying nucleosides to provide the necessary deoxy-
nucleosides that are not available from the host(s). In this
report, we present data that suggest that B. burgdorferi
both requires deoxypurines and deoxypyrimidines from its
host and makes use of a 2′-deoxyribosyltransferase to
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tissue sources of some deoxynucleosides are limiting.
Results
B. burgdorferi transports and incorporates nucleosides
and deoxynucleosides
The genome of B. burgdorferi does not harbour the genes
encoding enzymes for de novo purine and pyrimidine
biosynthesis.Furthermore,B. burgdorferiisdeﬁcientinthe
genes encoding central components of the ‘classic’ purine
salvage pathway, such as hypoxanthine-guanine phos-
phoribosyltransferase (Hpt), adenylosuccinate synthase
(PurA) and adenylosuccinate lyase (PurB), which have
been described in Borrelia hermsii, Borrelia duttonii and
Borreliarecurrentis(Barbouret al.,2005;Petterssonet al.,
2007; Lescot et al., 2008). In addition, it has been recently
demonstrated that B. burgdorferi does not contain the
gene operon for a RNR (Fraser et al., 1997; Barbour et al.,
2005; Pettersson et al., 2007). These data suggest that
B. burgdorferi must require exogenous sources of nucleo-
sides and deoxynucleosides for RNA and DNA synthesis.
To investigate this, B. burgdorferi cells were assayed
for their ability to transport and incorporate [3H]-
labelled nucleoside-5′-monophosphates (NMP) or
deoxynucleoside-5′-monophosphates(dNMP)intonucleic
acids. The NMPs and dNMPs were chosen for these
experiments because they are likely available in the tick
midgut and saliva during blood meal digestion and in host
tissue at the initial site of infection as a result of host cells
lysis and subsequent nucleic acid degradation due to
the innate immune response. However, NMPs and dNMPs
are not generally transported across cell membranes
(Nygaard, 1993). Instead, 5′nucleotidases in the cell mem-
brane speciﬁcally dephosphorylate NMPs or dNMPs to
nucleosides or deoxynucleosides to facilitate transport
(Yagil and Beacham, 1975). Genome analysis indicates
that B. burgdorferi harbours a putative 5′-nucleotidase
(bb0504) that contains a catalytic HD domain (a family of
metal-dependent phosphohydrolases) (Aravind and
Koonin, 1998) and a transmembrane domain (ExPASy
server) (Gasteiger et al., 2003). Furthermore, a putative
nucleoside ABC transporter system, encoded by a three-
gene operon (BB0677–79), has also been identiﬁed in
B. burgdorferi (Overbeek et al., 2003). Thus, we believe
that NMPs and dNMPs would be available during critical
stages of the infective cycle and effectively dephosphory-
lated and transported for incorporation into RNA and
DNA.
In the initial experiments, B. burgdorferi cells were
grown in Barbour-Stoenner-Kelly (BSK)II medium
containing [3H]-cytosine monophosphate (CMP) or
[3H]-deoxycytosine monophosphate (dCMP), followed by
isolation of RNA and DNA and quantiﬁcation of incorpo-
rated [3H] by scintillation counting. The results are shown
in Fig. 1 (columns labelled CMP and dCMP). When
B. burgdorferi cells were grown in the presence of
[3H]-CMP, the radiolabel was detected in the RNA (Fig. 1,
~400 fmol ng-1 of nucleic acid), but was not detected in
puriﬁed DNA. Conversely, when cells were grown in the
presence of [3H]-dCMP, the radiolabel was detected in
isolated DNA (Fig. 1, ~400 fmol ng-1 of nucleic acid), but
not in puriﬁed RNA. These data indicated that
B. burgdorferi was not able to convert cytosine to deoxy-
cytosine for incorporation into DNA. In contrast, when
B. hermsii cells were grown in the presence of [3H]-CMP,
the radiolabel was detected in both RNA and DNA (Fig. 1,
column labelled CMP; ~700 and 300 fmol ng-1 of nucleic
acid respectively), indicating that B. hermsii is able to
convert cytosine to deoxycytosine for DNA synthesis.
These results were not surprising as a RNR, for convert-
ing ribonucleotide diphosphate to 2′-deoxyribonucleotide
diphosphate, has been identiﬁed in B. hermsii (Barbour
et al., 2005; Pettersson et al., 2007). These data provided
experimental evidence for a functionally active RNR in
B. hermsii and the absence of such in B. burgdorferi.
To further assess the ability of B. burgdorferi to
transport and incorporate nucleic acid precursors,
B. burgdorferi cells were grown in the presence of
[3H]-labelled purines (AMP, dAMP, GMP or dGMP) and
Fig. 1. Nucleotide incorporation by
B. burgdorferi and B. hermsii using a variety
of [
3H]-labelled ribonucleotide and
deoxyribonucleotide pairs as substrates. Error
bars represent the standard deviation of
triplicate samples, normalized to either DNA
or RNA yield. Femtomoles of [
3H]-labelled
nucleotide incorporated were calculated from
the counts per min (cpm) and the speciﬁc
activity of the labelled substrate.
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described above and the results are shown in Fig. 1
(columns labelled AMP, dAMP, GMP and dGMP
respectively). Surprisingly, when cells were grown in the
presence of [3H]-AMP, the radiolabel was detected in both
DNA and RNA (~200 fmol ng-1 of nucleic acid in RNA and
DNA). Moreover, radiolabel was detected in DNA
(~600 fmol ng-1 of nucleic acid) and RNA(~50 fmol ng-1 of
nucleic acid) when cells were grown in the presence of
[3H]-dAMP. Similarly, when the cells were grown in the
presence of [3H]-GMP or [3H]-dGMP, the radiolabel was
detected in both the DNAand RNA(~50 and 100 fmol ng-1
of nucleic acid, respectively, for GMP and 100 and
50 fmol ng-1 of nucleic acid, respectively, for dGMP). In
comparison, when B. hermsii cells were grown in the
presence of [3H]-AMP, the radiolabel was detected in both
the DNA and RNA (Fig. 1, ~200 fmol ng-1 of nucleic acid
for RNA and DNA) at levels similar to those observed in
B. burgdorferi. As expected, [3H]-dAMP was incorporated
almost exclusively into DNA (Fig. 1, ~1400 fmol ng-1 of
nucleic acid in DNA compared with ~10 fmol ng-1 of
nucleic acid in RNA). When B. hermsii cells were grown in
the presence of [3H]-GMP or [3H]-dGMP, the levels of
incorporation of [3H] were similar to those observed in
B. burgdorferi. It is important to note that the levels of
incorporation of [3H]-GMP and [3H]-dGMP in both bacteria
were much lower than those observed with [3H]-AMP or
[3H]-dAMP, suggesting that B. burgdorferi and B. hermsii
were inefficient at transporting and/or incorporating gua-
nosine (Guo) and deoxyguanosine (dGuo). These data
suggested that in the absence of a RNR, an alternative
route for generating reduced ribonucleotides for purine
metabolism must be present in B. burgdorferi and an
alternate biochemical pathway must exist to supplement
inefficient Guo and dGuo transport in B. burgdorferi, dis-
tinct from that described in B. hermsii (Barbour et al.,
2005; Pettersson et al., 2007).
BB0426 encodes a purine-speciﬁc
2-deoxyribosyltransferase
Close inspection of the B. burgdorferi genome revealed a
plausible explanation for the RNR-like biochemical activity
observed in the purine incorporation assay. While initial
genome analyses had provided no evidence for this activ-
ity, a sequence search using Pfam (Finn et al., 2006)
identiﬁed BB0426 as a potential member of a group of
2′-deoxyribosyltransferases (DRTases) (PF05014) that
are involved in nucleoside/deoxynucleoside recycling in
Lactobacillus species (Fig. 2) (Kaminski, 2002). The basis
for this match was centred on near-identical active site
residues that have been determined to be critical for sub-
strate binding and enzyme catalysis (Fig. 2B) (Anand
et al., 2004). There are two classes of DRTases: DRTase
Fig. 2. Amino acid alignment of the 2′-deoxyribosyltransferase of Lactobacillus species, Ureaplasma and B. burgdorferi BB0426.
A. Alignment of Lactobacillus helveticus DRTase I active site residues (indicated by shaded boxes) and the catalytic residue unique to DRTase
II (asterisk) (Anand et al., 2004) with the sequences of BB0426 and some other members of Pfam 05014 (Finn et al., 2006).
B. Spatial arrangement of amino acid residues involved in deoxynucleoside binding with an dAdo molecule shown in bold (Anand et al., 2004).
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moiety between purine bases exclusively, while DRTase II
enzymes can also transfer a 2′-deoxyribose between two
pyrimidines or between pyrimidines and purines. To deter-
mine the biochemical properties of BB0426, an optimized
bb0426 was synthesized using the codon preferences for
expression in Escherichia coli (GeneArt). The optimized
gene, bb0426-opt, was cloned into pET17b and the
T7-tagged, recombinant protein was puriﬁed to apparent
homogeneity (Fig. 3A).
To measure deoxyribosyltransferase activity, the puri-
ﬁed protein was combined with various substrates to
serve as either donors or acceptors of the deoxyribose
moiety and the reactions monitored by HPLC at an absor-
bance of 254 nm (Fig. 3B). Control assays were per-
formed with heat-inactivated enzyme. Initial assays which
used deoxyinosine (dI) as the deoxyribose donor and
adenine (Ade) as the deoxyribose acceptor resulted in the
generation of deoxyadenosine (dAdo) and hypoxanthine
(Hyp), with a speciﬁc activity determined to be
42  4.9 nmol min-1 mg-1 (Table 1). Figure 3B is a repre-
sentative HPLC chromatogram showing the conversion of
Ade to dAdo when dI was used as a donor. At reaction
t i m eo f0m i n( t 0), theA240 ofAde and dI was approximately
Fig. 3. Puriﬁcation and characterization of
BB0426opt.
A. Commassie-stained SDS-PAGE gel with
(1) E. coli lysate expressing BB0426opt and
eluted fraction from a T7 affinity column.
B. HPLC chromatograms showing the
enzymatic activity of BB0426opt. In this assay,
deoxyinosine (dIno) served as the
deoxyribosyl donor and adenine (Ade) the
deoxyribosyl acceptor: deoxyadenosine
(dAdo) and hypoxanthine (Hyp) are the
products of the reaction.
Table 1. Speciﬁc activities of BB0426opt with various substrates compared with DRTase I
a and DRTase II
a from Lactobacillus helveticus
(Kaminski, 2002).
Deoxyribose donor Acceptor Enzymatic product
Speciﬁc activity (nmol min
-1 mg
-1)
B. burgdorferi L. helveticus
BB0426 DRTase I DRTase II
Purines
Deoxyinosine Adenine Deoxyadenosine 42  1.2
b 83 3
Deoxyinosine Guanine Deoxyguanosine 45  4.9 – –
Deoxyadenosine Hypoxanthine Deoxyinosine 16  2.5 61 8
Deoxyadenosine Guanine Deoxyguanosine 94  2.4 – –
Deoxyguanosine Adenine Deoxyadenosine 85  10.2 50 16
Deoxyguanosine Hypoxanthine Deoxyinosine 18  0.7 54 3
Deoxyadenosine monophosphate Hypoxanthine Deoxyinosine < 1– –
Deoxyguanosine monophosphate Hypoxanthine Deoxyinosine < 1– –
Pyrimidines
Deoxythymidine Cytosine Deoxycytosine < 1 < 12 8
Deoxycytosine Thymine Deoxythymidine 2 < 13 2
Purine/pyrimidine
Deoxyinosine Cytosine Deoxycytosine < 1 < 18
Deoxyadenosine Cytosine Deoxycytosine < 1 < 13 4
a. DRTase I or II: deoxyribosyltransferase class I or II.
b. Mean values and standard deviations represent triplicate analyses.
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(t20), the absorbance of both had decreased to approxi-
mately 40 mAU. The decrease in Ade and dI concentra-
tions corresponded to a subsequent increase in the
absorbance of dAdo (Fig. 3B: from ~1 mAU at t0 to
~1 0m A Ua tt 10) and of Hyp (the product generated from
the removal of the deoxyribosyl moiety from dI), from
~5 mAU at t0 to ~20 mAU at t10. Other purines were used
as deoxyribose donors (i.e. dAdo and dGuo) and accep-
tors Hyp, guanine (Gua) and Ade, and the speciﬁc activity
of BB0426opt with each potential deoxyribose donor was
measured by HPLC. The results are shown in Table 1.
The speciﬁc activities range from 16  2.5 nmol min-1
mg-1 (dAdo to Hyp) to 94  2.4 nmol min-1 mg-1 (dAdo to
Gua) and indicated that BB0426opt was able to effectively
transfer the deoxyribose from any deoxypurine to any
purine base. However, puriﬁed BB0426opt was not able to
transfer the deoxyribosyl moiety from purine donors to
pyrimidines (e.g. dI to cytosine) or between pyrimidines
(e.g. deoxythymidine to cytosine) (Table 1). Taken
together, these results indicate that BB0426 is a member
of the purine-speciﬁc DRTase I subfamily and the activity
of BB0426 could explain the observed incorporation of
purine nucleosides into DNA.
The fate of hypoxanthine in B. burgdorferi
Previously, it was demonstrated that B. hermsii, a closely
related member of the Borrelia genus, has a classic purine
salvagepathway,includinggenesencodingaclassIbRNR
(Barbour et al., 2005; Pettersson et al., 2007). Further-
more, it was shown that B. burgdorferi is able to incorpo-
rate [3H]-Hyp into RNA and DNA (Pettersson et al., 2007).
This result was puzzling as B. burgdorferi lacked a hypox-
anthine phosphoribosyltransferase (Hpt), an adenylosuc-
cinate synthase (PurA) and an adenylosuccinate lyase
(PurB), which have a suggested involvement in the incor-
poration of Hyp into RNA and DNA in B. hermsii (Petters-
son et al., 2007). However, the activity of BB0426opt (e.g.
Hyp + dAdo yielded dI + Ade) might explain these data. To
determine the fate of Hyp in B. burgdorferi, cells were
grown in BSKII containing [3H]-Hyp, the RNA and DNA
puriﬁed and assayed for radioactivity as described above.
The results are shown in Fig. 4A (column labelled B31A3
68-1). The amount of [3H]-Hyp incorporated into the DNA
was ~8f m o ln g -1 of nucleic acid, while the amount incor-
porated into RNA was approximately 5¥ that level at
~38 fmol ng-1 of nucleic acid. As previously observed,
these data conﬁrmed that Hyp was incorporated into the
nucleic acids of B. burgdorferi even in the absence of an
Hpt. One explanation for the incorporation of Hyp into RNA
is due to the presence of a xanthine-guanine phosphoribo-
syltransferase (gpt, BB0103) (Table 2), which could poten-
tially convert Hyp to IMP, and then be converted to GMPby
IMP dehydrogenase (GuaB) (Zhou et al., 1997) and GMP
synthase (GuaA) (Margolis et al., 1994) for incorporation
into RNA. However, the presence of [3H]-label in the DNA
of B. burgdorferi was difficult to explain. To determine the
speciﬁc base containing the [3H]-label in the puriﬁed DNA,
the DNA from the [3H]-Hyp incorporation assays was
Fig. 4. [
3H]-Hyp conversion and incorporation into nucleic acids.
A. [
3H]-Hyp conversion and incorporation into the RNA and DNA of strains B31A3 68-1, DguaAB, DguaAB/pBSV2G (vector control) and
DguaAB/pBSV2G guaAB (complement). Femtomoles of [
3H]-Hyp incorporated were calculated from the counts per minute (cpm) and the
speciﬁc activity of the labelled substrate. Error bars represent the standard deviations of triplicate samples.
B. HPLC analyses of the incorporation of [
3H] into individual deoxynucleosides of DNA isolated from [
3H]-Hyp labelled B. burgdorferi cells. The
left side of the z-axis, [
3H]-Hyp was determined to be incorporated primarily as dGuo. The right of the z-axis shows the per cent composition
of unlabelled DNA as a control to verify that DNA digestion went to completion.
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nucleosides fractionated by HPLC. These results are
shown in Fig. 4B. According to these data, > 99% of the
[3H]-label was detected in dGuo, indicating that Hyp was
being converted to dGMP for incorporation into the DNAof
B. burgdorferi.
Given these results, it appeared likely that [3H]-Hyp
incorporation into B. burgdorferi DNA was due to the
enzymatic activity of BB0426. Puriﬁed BB0426opt was able
to transfer the deoxyribosyl moiety from dAdo (or dGuo) to
Hyp, yielding dI (Table 1). We then speculated that dI
could be phosphorylated to dIMP and converted to dGTP
by IMP dehydrogenase (GuaB), GMP synthase (GuaA),
deoxyguanosine kinase (Dgk) and nucleoside diphos-
phate kinase (Ndk). To test this hypothesis, a GuaA
mutant (guaA::kan), in which an antibiotic-resistance cas-
sette was inserted 559 bp downstream of the guaA start
codon resulting in a 229 bp deletion (Fig. 5A), was exam-
ined for the ability to incorporate [3H]-Hyp. Unlike wild-
type B. burgdorferi, the digested puriﬁed DNA isolated
from strain guaA::kan cells, grown in the presence of
[3H]-Hyp, contained no [3H]-dGuo, indicating that this
mutant was unable to biochemically convert [3H]-Hyp to
[3H]-dGTP (data not shown). However, this mutant did
incorporate [3H]-Hyp into DNA as [3H]-dAdo (data not
shown), an activity not present in the wild-type bacteria.
One possible explanation for these results is that the
location of the antibiotic-resistance cassette in strain
Table 2. Enzymes involved in B. burgdorferi purine salvage pathway.
Enzyme name Gene designation Open reading frame Reference
Adenine deaminase adeC bbk17 Jewett et al. (2007b)
Adenine phosphoribosyltransferase apt bb0777 Overbeek et al. (2003)
Adenylate kinase adk bb0417 Overbeek et al. (2003)
Deoxynucleoside kinase dgk bb0239 Overbeek et al. (2003)
Deoxyribosyltransferase ptd bb0426 Finn et al. (2006)
GMP synthase guaA bbb18 Margolis et al. (1994)
IMP dehydrogenase guaB bbb17 Zhou et al. (1997)
Guanine-hypoxanthine permease pbuG bbb22–23 Byram et al. (2004)
Nucleoside transport system (ABC) mglA, mglC1, mglC2 bb0677–79 Overbeek et al. (2003)
Nucleotidase – bb0504 Gasteiger et al. (2003)
Nucleoside phosphorylase – bb0588, bb0375, bbi06 Overbeek et al. (2003)
Nucleoside diphosphate kinase ndk bb0463 Overbeek et al. (2003)
Xanthine-guanine phosphoribosyltransferase gpt bb0103 Pettersson et al. (2007)
Fig. 5. Characterization of guaA::kan and DguaAB mutant strains.
A. Diagram of gene organization for wild-type guaAB, as well as the insertion points of antibiotic-resistance cassettes for the two mutant strain
constructs (guaA::kan and DguaAB). The positions of the primers used for PCR are identiﬁed by number and correspond to those listed in
Table 3. The location of GATase and PP-ATPase catalytic domains in guaA are indicated by rectangular boxes.
B. Agarose gel containing PCR products using genomic DNA from the speciﬁed B. burgdorferi strains and primer sets corresponding to the
target gene of interest. Standards in base pairs are shown on the left. Predicted product size (in base pairs) for each primer pair is indicated
in the inset table.
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domain of GuaA, and this truncated gene product con-
ferred an enzymatic activity not present in the wild-type
strain (Fig. 5A). The function of the GATase domain in
guaA is to liberate ammonia from glutamine and transfer
it to the enzyme’s ATP-pyrophosphatase domain for con-
version of XMP to GMP (Abbott et al., 2006). In the
absence of the second domain, it is possible that residual
activity of the truncated protein was somehow responsible
for the anomalous data observed with this mutant. To test
this, a guaAB deletion mutant was constructed by replac-
ing the guaAB coding region with a spec/strep-resistance
cassette through allelic exchange. The deletion of the
guaAB operon was conﬁrmed by PCR (Fig. 5A). This
mutant, designated B31A3 68-1 DguaAB, was engineered
to eliminate the entire guaAB operon, including the coding
region for the GATase catalytic domain that was present in
the original guaA::kan mutant. When B31A3 68-1 DguaAB
cells were grown in the presence of [3H]-Hyp, no radioac-
tivity was detected in the puriﬁed DNA or RNA (Fig. 4A).
These results suggested that the GATase catalytic domain
was most likely responsible for the spurious activity
observed in the original guaA::kan mutant. Therefore, we
elected to use the DguaAB mutant in these biochemical
studies.
The DguaAB mutant was complemented by cloning a
wild-type copy of guaAB into the shuttle vector pBSV2G
and this construct, or the empty shuttle vector, was intro-
duced into the DguaAB mutant (Table 3). These strains
were then tested for incorporation of [3H]-Hyp as
described above. When clone DguaAB/pBSV2GguaAB
was grown in BSKII containing [3H]-Hyp, radioactivity
was detected in both RNA and DNA (~32 and
28 fmol ng-1 nucleic acid respectively) (Fig. 4A). As a
control, the deletion mutant containing an empty shuttle
vector was grown in the presence of [3H]-Hyp. In these
cells, no radioactivity was detected (Fig. 4A). These data
indicated that the incorporation of the [3H]-Hyp was
indeed due to the presence of the guaAB operon. It
should be noted that strain DguaAB/pBSV2GguaAB cells
incorporated higher levels of [3H]-Hyp than did the wild-
type bacteria. This result could be due to the increased
copy number (5–10 copies per cell) of pBSV2GguaAB in
these cells (Tilly et al., 2006). The puriﬁed DNA isolated
from strains B31A3 68-1 and DguaAB/pBSV2GguaAB
grown in BSKII containing [3H]-Hyp was degraded and
analysed by HPLC to determine the speciﬁc DNA base
containing the [3H]-label. In both cases, the incorporated
[3H]-Hyp was converted into dGuo (data not shown).
These results indicated that the guaAB operon was
required for incorporation of Hyp into the nucleic acids of
B. burgdorferi and that dGuo is the sole DNA product of
Hyp metabolism in this bacterium. These data also dem-
onstrate that B. burgdorferi was unable to convert Hyp to
AMP, conﬁrming the lack of a functional PurAB (adeny-
losuccinate synthase/lyase) for the conversion of IMP to
Table 3. B. burgdorferi strains and primers used in this study.
Clone Genotype Plasmids lost Reference
B. hermsii DAH Wild-type Unknown Hinnebusch et al. (1998)
B31A3 68-1 Parent strain cp9, lp25, lp56 This study
B31A3 M9 Parent strain cp9, lp21 Tilly et al. (2004)
guaA::kan A3 M9 guaA:: ﬂgBp-kan cp9, lp21 This study
DguaAB A3 68-1 guaAB::ﬂaBp-aadA cp9, lp25, lp56 This study
DguaAB/pBSV2G A3 68-1 guaAB::ﬂaBp-aadA cp9, lp25, lp56 This study
DguaAB/pBSV2G
guaAB
A3 68-1 guaAB::ﬂaBp-aadA/
pBSV2G guaAB
cp9, lp25, lp56 This study
Number Primer name Sequence
p1 guaB -500 5′-TGCTGATCCTATGACGTTCTTAAGC-3′
p2 guaA +500 5′-TAGGGTTGATATTGCATAAGCTCCCGC-3′
p3 guaB 13852-SalI 3′ 5′-GCGTCGACAAAAGATCAAAATATTGCATCCTTC-3′
p4 guaA 16727-SalI 5′ 5′-GCGTCGACAGCATATTTGGCTTTGCTTATGTCG-3′
p5 ﬂaB-XhoI 5′ 5′-CCGCTCGAGCTGTCGCCTCTTGTGGCTTC-3′
p6 aadA-XhoI 3′ 5′-CCGCTCGAGTTATTTGCCGACCTACCTTGG-3′
p7 guaAcompF-SalI 5′-GCGTCGACGGTTTATAGCTAGATCTTTTGATTTGGC-3′
p8 guaAcompRC-SalI 5′-GCGTCGACTCAGCAGAATTTGCAGATGTATTCCC-3′
p9 guaA F 5′-GATTTTGGATCCCAATATAGCC-3′
p10 guaA R 5′-CCCATTCTATGGTTGATGGAGGCTTAGA-3′
p11 kan 5-NdeI 5′-CATATGAGCCATATTCAACGGGAAACG-3′
p12 kan term XbaI 5′-GCTCTAGACTAGCGCCGTCCCGTCAA-3′
p13 guaA16159-SalIF 5′-GTCGACGGATGGAATTGTAGGCCG-3′
p14 guaA15926-SalIRC 5′-GTCGACGTAAACACTGGATTGTTGCGC-3′
p15 ﬂgBPo-XhoI 5′-TAATACTCGAGCTTCAAGGAAGATTT-3′
p16 aacC1-NheI 5′-GCTAGCCGATCTCGGCTTGAACG-3′
Purine metabolism in Borrelia burgdorferi 1523
Journal compilation © 2009 Blackwell Publishing Ltd, Molecular Microbiology, 72, 1517–1529
No claim to original US government worksAMP as suggested by previous genomic and Southern
blot analyses (Fraser et al., 1997; Barbour et al., 2005;
Pettersson et al., 2007).
IMP dehydrogenase possesses secondary substrate
activity for dIMP
The guaB gene in B. burgdorferi has been previously
shown to encode a functional inosine-5′-monophosphate
dehydrogenase (Zhou et al., 1997). The reported activity
of the inosine-5′-monophosphate dehydrogenase in
B. burgdorferi is the catalysis of IMP oxidation to XMP
with a corresponding reduction of NAD+ to NADH. In
organisms containing an active RNR, the GuaAB pathway
serves the dual purpose of producing guanine nucleotides
for RNA (GTP) and after enzymatic reduction of GDP by
RNR and subsequent phosphorylation, dGTP for DNA
synthesis. In the absence of an active RNR, the mecha-
nism for dGTP production in B. burgdorferi was not imme-
diately obvious. Our preliminary [3H]-Hyp incorporation
data suggested a critical role for GuaAB in the purine
salvage pathway and DNA synthesis in B. burgdorferi.
Furthermore, the incorporation data strongly suggested
that in addition to the previously published activity,
B. burgdorferi GuaB could also catalyse the conversion of
dIMP to dXMP. To determine if GuaB could catalyse this
conversion, the activity of GuaB from B. burgdorferi was
examined when puriﬁed recombinant protein was com-
bined with dI, dIMP or IMP substrates. When dIMP or IMP
was used as a substrate in the reaction mixture, the
conversion of dIMP to dXMP or IMP to XMP was detected
and the Km calculated to be 66 mMo r2 0 8mM respectively.
Additionally, no activity was detected when dI was used as
a substrate, indicating that the phosphorylation of inosine
or dI to IMP or dIMP, respectively (presumably by dgk),
was required before conversion to XMP or dXMP. The
ability of GuaB to convert dIMP to dXMP provided a criti-
cal link for the multistep conversion of Hyp to dGTP and
subsequent utilization for DNA synthesis. Based upon the
data presented, we propose a novel pathway for purine
salvage that circumvents the need for a RNR in
B. burgdorferi that includes the transport of deoxynucle-
otide precursors, the activity of a deoxyribosyltransferase
and the concerted activities of GuaAB (Fig. 6).
Discussion
The genome of B. burgdorferi contains few genes encod-
ing enzymes for de novo biosynthesis of amino acids, fatty
acidsornucleobasesandthus,itmustrelyonitsarthropod
vector or various vertebrate hosts to provide these ‘essen-
tial’ components of cellular macromolecules. While the
Fig. 6. Proposed purine salvage pathway for B. burgdorferi. This diagram represents a proposed pathway for purine salvage based upon the
experimental data presented in this report and genome data annotated in ERGO (Fraser et al., 1997; Overbeek et al., 2003). The
deoxyribosyltransferase, BB0426, is shaded to highlight its pivotal role in this pathway. Genes assigned putative activities for non-speciﬁc
substrates are designated with an asterisk. These assignments were based on activities reported for homologous genes in the BRENDA
database (Chang et al., 2009).
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and fatty acids for glycolipids, lipids and lipoproteins syn-
thesis have been partially deﬁned (reviewed in Gherardini
et al., 2009), little is known about the requirements for
nucleobases in B. burgdorferi. Typically, bacteria lacking
the de novo synthesis of bases must rely on ‘salvage’
pathways for the utilization of bases and/or nucleosides for
RNA and DNA synthesis. In general, these pathways
include enzymes for the conversion of bases to nucleo-
sides for RNA synthesis (or energy storage, e.g. ATP or
GTP) or to reduce NDPs or NTPs to deoxynucleotides
(catalysed by RNRs) for DNA synthesis.
Cross-genome comparisons between the Lyme
disease spirochaete and the relapsing fever spirochaetes
(B. hermsii, B. recurrentis and B. duttonii), which encode
an operon for a class Ib RNR (Barbour et al., 2005; Pet-
tersson et al., 2007; Lescot et al., 2008), did not identify
similar gene(s) in B. burgdorferi (Barbour et al., 2005; Pet-
tersson et al., 2007). While we and others were unable to
detect an RNR homologue in B. burgdorferi, it was still
possible that B. burgdorferi might harbour proteins with
similar enzymatic activity but divergent in gene sequence.
This possibility was tested experimentally using the incor-
poration of the radio-labelled pyrimidine ribonucleotide
CMP. When cells were grown in the presence of [3H]-CMP,
radioactivity was only detected in the RNA, not the DNA,
indicating that B. burgdorferi was not able to enzymati-
cally catalyse the reduction of the ribonucleotides (Fig. 1,
column labelled CMP). Thus without a RNR, it seemed
likely that B. burgdorferi required host-derived sources of
deoxynucleosides, as well as nucleosides, for growth.
Like B. burgdorferi, U. urealyticum does not encode an
RNR operon, suggesting that this bacterium is dependent
upon the uptake of deoxypurines and deoxypyrimidines
from the host (Glass et al., 2000). Subsequent studies
have demonstrated that U. urealyticum does, in fact,
transport purine and pyrimidine deoxynucleosides and
after phosphorylation by thymidine or deoxyadenosine
kinase, incorporate these precursors into DNA (Carnrot
et al., 2003). Bacillus subtilis and Bacillus mojavensis
have also been shown to require deoxynucleosides for
DNA synthesis when the organisms are grown anaerobi-
cally (Folmsbee et al., 2004). Because the class Ib RNR
in Bacillus requires oxygen to be catalytically active, the
bacterium must rely upon uptake of deoxynucleosides for
DNA replication when the cells are grown in the absence
of oxygen (Folmsbee et al., 2004). Thus, it is clear that
some bacterial species can survive and replicate by scav-
enging exogenous deoxynucleosides in lieu of a func-
tional RNR.
When purine substrates were tested in the nucleotide
incorporation assay, it appeared that B. burgdorferi was
capable of generating reduced purine ribonucleotides
(Fig. 1,columnlabelledAMPandGMP).Inaddition,purine
deoxynucleosides (dAdo and dGuo) were incorporated
into RNA (Fig. 1, column labelled dAMP and dGMP), sug-
gesting nucleotide phosphorylase activity. These observa-
tions suggested biochemical deviations from the classic
salvage pathway and led to a series of experiments to
understand these experimental data. Bioinformatics
revealed an open reading frame in B. burgdorferi (bb0426)
that putatively encoded a protein with active site residues
similar to a 2′-deoxyribosyltransferase (Fig. 2) (Anand
et al., 2004; Finn et al., 2006). Furthermore, microarray
analysis has demonstrated that bb0426 is constitutively
expressed in B. burgdorferi (J.A. Boylan, unpubl. data),
suggesting that the gene is transcribed during mid-log
phase of growth. N-deoxyribosyltransferases (DRTase)
are represented by two classes of enzymes: DRTase I
enzymes catalyse the transfer of 2′-deoxyribose from a
purine deoxynucleoside to a purine base exclusively, while
DRTase II enzymes are able to transfer a 2′-deoxyribose
fromanydeoxynucleosidedonortopyrimidines,purinesor
between pyrimidine and purine bases (Kaminski, 2002).
The structure and functions of these enzymes have been
well characterized in Lactobacillus species. Lactobacillus
helveticus harbours genes encoding both a DRTase I (also
designated as Ptd) and a DRTase II (also designated as
Ntd)(Kaminski,2002;Anandet al.,2004).AsLactobacillus
species contain functional RNRs, it seems likely that the
primary function of the DRTases in this bacterium is to
recycle 2′-deoxynucleosides to maintain nucleotide pools
for DNA synthesis. It is interesting to note that bb0426
homologues were identiﬁed in the genomes of Lyme
disease spirochaetes while no homologues were found
in the genomes of relapsing fever Borrelia, Treponema
or Leptospira, all of which harbour genes encoding
RNRs.
Kinetic studies with puriﬁed recombinant BB0426opt
demonstrated similar function and activity to those
reported for L. helveticus DRTase I (Table 1) (Kaminski,
2002). Puriﬁed B. burgdorferi BB0426opt was able to trans-
fer a deoxyribosyl moiety from dAdo to Gua or from dGuo
to Ade yielding dGuo or dAdo respectively. However,
BB0426opt was not able to transfer the deoxyribose group
from deoxypyrimidines or deoxypurines to pyrimidine
nucleobases, suggesting that it had activity similar to
L. helveticus DRTase I, not DRTase II. It is interesting to
note that deoxypurine monophosphates did not act as
deoxyribose donors, suggesting that once the deoxy-
nucleosides were phosphorylated, they were committed
to incorporation into DNA. The enzymatic activity of
BB0426 reported here provided an explanation for the
radiolabel incorporation of AMP, GMP, dAMP and dGMP
observed in B. burgdorferi (Fig. 1). For example, dAMP
would be dephosphorylated, transported into the cell and
BB0426 would transfer the deoxyribosyl moiety from
dAdo to Gua yielding dGuo and Ade. Ade would then be
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(Apt, encoded by bb0777) and toATP by Ndk (encoded by
bb0463) for incorporation into RNA (Fig. 6). Likewise,
AMP could be dephosphorylated to Ado, transported into
the cell and phosphorylated to ATP for RNA synthesis
(Fig. 6). Additionally, Ado could be hydrolysed to Ade and
ribose 5-phosphate by purine nucleoside phosphorylase
(putatively encoded by bb0588, bb0375 and/or bbI06) and
Ade could then be converted to dAdo by BB0426 and to
dATP for DNA synthesis. Based upon experimental data
presented here, it is likely that B. burgdorferi utilizes
BB0426 (with the activities of enzymes outlined in Fig. 6)
for purine salvage in lieu of a RNR to maintain sufficient
levels of purine ribonucleosides and deoxynucleosides for
RNA and DNA synthesis.
Additionally, and perhaps as important, puriﬁed
BB0426opt was shown to transfer the deoxyribosyl moiety
from either dAdo or dGuo to Hyp yielding dI. Previously,
Pettersson et al. (2007) reported that B. burgdorferi could
incorporate Hyp into RNA and DNA. The activities of
BB0426 reported here could explain these data. Following
conversion of Hyp to dI by BB0426, it is likely that, after
phosphorylation to dIMP, GuaB converts dIMP to dXMP,
which could then be converted to dGMP by GMP synthase
(GuaA). Indeed, we were able to experimentally establish
that puriﬁed, recombinant GuaB converted dIMP to dXMP.
Moreover,analysesofDNAisolatedfromcellslabelledwith
[3H]-Hyp showed that >99% of the label was incorporated
into dGuo (Fig. 4B). These results demonstrated that Hyp
can be utilized via two pathways for incorporation into
nucleic acids (Fig. 6). First, following a typical purine
salvage pathway, Hyp is converted to IMP by a phospho-
ribosyltransferase (Apt or Gpt), and to GMP by GuaAB for
incorporation into RNA. Or second, Hyp can be ribosylated
by BB0426, and after phosphorylation by deoxynucleoside
kinase (Dgk), can be converted to dGMP by GuaAB for
incorporation into DNA. This pathway illustrates how
purine salvage in B. burgdorferi has evolved in the
absence of a RNR. It is important to stress that for survival,
B. burgdorferi must have an external source of deoxypu-
rines and deoxypyrimidines for DNA synthesis. Addition-
ally, if exogenous sources of dGMP are limited, or to
supplement dGuo transport, the activities of BB0426,
GuaAand GuaB provide an alternate pathway to generate
dGTP from salvaged Hyp. This simple adaptation makes it
possible for B. burgdorferi to colonize and successfully
infecthosttissueswhenguaninenucleotideprecursorsare
at levels too low to support growth.
Experimental procedures
Bacterial strains and culture conditions
All B. burgdorferi strains used in this study are listed in
Table 3 and are derived from strain B31 cloneA3, which lacks
the plasmid cp9 but harbours all 20 other plasmids described
in the parental strain MI-B31 (Elias et al., 2002). Strain A3
68-1 was derived by introducing strain A3 into a mouse,
followed by reisolation, plating and screening single colonies
for loss of lp25 and lp56. B. burgdorferi and B. hermsii were
grown in liquid BSKII medium supplemented with 6% rabbit
serum (Barbour, 1984). B. burgdorferi was plated in solid
BSK medium as previously described (Rosa and Hogan,
1992). All cultures were grown at 34°C with 2.5% CO2 and
antibiotics were added as required (kanamycin: 200 mgm l
-1,
gentamicin: 40 mgm l
-1 and streptomycin: 50 mgm l
-1). E. coli
strains were grown in Luria broth containing the appropriate
antibiotics (kanamycin: 50 mgm l
-1, ampicillin: 100 mgm l
-1).
Construction of the guaAB mutants
To construct the guaA::ﬂgBp -kan mutant, the guaA gene was
ampliﬁed from B31 genomic DNA using primers 9 and 10
(Table 3) and cloned into the vector pCR-XL-TOPO (Invitro-
gen, Carlsbad, CA), yielding pguaA. A 233 bp region of guaA
(amino acids 185–264) was removed from pguaA by inverse
PCR using the Expand Long PCR system (Roche, Indianapo-
lis, IN) and primers 13 and 14 (Table 3), yielding linear pguaA-
mut with SalI sites at its ends. The kanamycin-resistance
cassette, ﬂgBp-kan (Bono et al., 2000), was ampliﬁed from
pBSV2 (Stewart et al., 2001) with XhoI ends, using primers 15
and 16 (Table 3), and cloned into the pCR2.1-TOPO vector
(Invitrogen). The ﬂgBP-kan gene cassette was removed from
the pCR2.1-TOPO vector by XhoI digestion and ligated into
inactivation constructs digested with SalI to create
pguaA::ﬂgBP-kan. Twenty micrograms of pguaA::ﬂgBP-kan
plasmid DNApuriﬁed from E. coli was transformed intoA3-M9
as previously described (Samuels, 1995; Elias et al., 2002;
Grimm et al., 2004) and the recombinants were selected in
solid BSK medium containing kanamycin. Colonies were
screened by PCR for the presence of the kanamycin-
resistancecassettewithintheguaAlocus,usingprimers1and
2 (Table 3). Total genomic DNA was prepared from PCR-
positive A3-M9 guaA::ﬂgBP-kan clones and screened with a
panelofprimersforthepresenceofallB. burgdorferiplasmids
(Eliaset al.,2002).Aclonethatretainedtheplasmidcontentof
the parent strain was used in further experiments.
To construct the B. burgdorferi DguaAB mutant, the guaAB
genes were deleted from the B. burgdorferi strain A3 68-1 by
allelic exchange using the spectinomycin/streptomycin-
resistance cassette, ﬂaBp -aadA (Jewett et al., 2007a).
Brieﬂy, a 3.9 kbp fragment that included guaAB and 500 bp of
ﬂanking upstream and downstream sequence, was ampliﬁed
from B31 strain A3 genomic DNA using the Expand Long
PCR system (Roche) and primers 1 and 2 (Table 3). The PCR
product was ligated into pCR-XL TOPO (Invitrogen) generat-
ing pguaAB. A 2.9 kbp guaAB DNA fragment was removed
from pguaAB by inverse PCR using the Expand Long PCR
system (Roche) and primers 3 and 4 (Table 3), yielding linear
pDguaAB with SalI restriction sites at each end. The
spectinomycin/streptomycin-resistance cassette, ﬂaBp-aadA
(Jewett et al., 2007a), was ampliﬁed using primers 5 and 6
(Table 3). The PCR product containing ﬂaBp-aadA was
treated with XhoI and ligated into SalI cut-pDguaAB, yielding
pDguaAB::aadA. Twenty micrograms of pDguaAB::aadA
plasmid DNA puriﬁed from E. coli was transformed into strain
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2002; Grimm et al., 2004) and the recombinants were iso-
lated on solid BSK medium containing streptomycin. Colo-
nies were screened by PCR to insure that the streptomycin-
resistance cassette had replaced guaAB using either primer
pairs 1 and 2 or 5 and 6 (Table 3). Total genomic DNA was
prepared from PCR-positive A3 68-1 DguaAB:: ﬂaBp-aadA
strains and screened with a panel of primers for the presence
of all B. burgdorferi plasmids (Elias et al., 2002). A strain that
retained the B. burgdorferi plasmid content of the parent
strain was used in further experiments.
Complementation of the DguaAB mutant
The DguaAB mutant was complemented with pBSV2G
guaAB, a shuttle vector carrying a wild-type copy of the
guaAB operon and native promoter. Plasmid pBSV2G guaAB
was constructed by PCR-amplifying a 3.4 kbp DNA fragment
containing the guaAB operon and its putative promoter region
with SalI ends from wild-type B. burgdorferi genomic DNA,
using Vent polymerase (Invitrogen) and primers 7 and 8
(Table 3). TA ends were added to this DNA fragment using
Taq polymerase and the product cloned into the vector
TOPO-XL (Invitrogen). The 3.4 kbp guaAB DNA fragment
was removed from TOPO-XL by SalI digestion and cloned
into the B. burgdorferi shuttle vector pBSV2G (Elias et al.,
2002) digested with SalI. The plasmid structure and
sequence were analysed and veriﬁed by restriction digestion
and sequence analysis. The guaAB mutant was transformed
with the pBSV2G guaAB plasmid and positive transformants
were selected as previously described (Jewett et al., 2007b).
Astrain that retained the B. burgdorferi plasmid content of the
parent strain was used in further experiment.
Cloning, overexpression and puriﬁcation of BB0426
To characterize the putative 2′-deoxyribosyltransferase
(BB0426), the native nucleotide sequence from
B. burgdorferi was codon-optimized for expression in E. coli
(Boylan et al., 2006) (sequence available upon request) and
the synthetic gene, BB0426opt (GeneArt, Burlingame, CA)
was ligated into expression vector pET17b (Novagen,
Madison, WI), which introduces a T7 epitope into the recom-
binant protein. The construct was transformed into E. coli
strain BL21 pLysS (Novagen) and gene expression induced
with IPTG. Cells expressing recombinant BB0426 opt were
lysed using a French pressure cell (12 000 psi) and cell
debris was removed by centrifugation (10 000 ¥ g for 15 min
at 4°C). The supernatant was applied to a T7 Affinity column
(Novagen) and puriﬁed protein was eluted as described in the
manufacturer’s protocol. The purity of BB0426opt was
estimated by SDS-PAGE, and protein concentration was
determined using a BCA protein assay kit (Sigma-Aldrich,
St Louis, MO).
2-deoxyribosyltransferase assay
Puriﬁed recombinant BB0426opt (1.5 mg) was added to a 1 ml
reaction mixture containing 20 mM of a deoxyribose donor
and 20 mM deoxyribose acceptor in 50 mM potassium phos-
phate buffer at pH 6.0. Reaction mixtures were incubated at
37°C and 230 ml aliquots were removed at 0, 5, 10 and
20 min intervals. Negative controls were prepared in the
same manner, except that the enzyme was heat-inactivated
at 95°C for 10 min. A standard curve was generated for each
substrate and potential products tested at the following con-
centrations; 2.0, 5.0, 7.0 and 10.0 mM respectively. HPLC
analyses were conducted on an Agilent 1200 system using a
Supelcosil LC-18-S 4.6 mm ¥ 150 mm, 5 mm analytical
column (Supelco, Park Bellefonte, PA). Samples, standards
and controls were ﬁltered through a 0.45 mm membrane and
50 ml was injected onto the column equilibrated with 50 mM
potassium phosphate, pH 4.5 containing 8% methanol. The
products were eluted using an isocratic gradient for 20 min
while UV absorbance was monitored at 254 nm. A unit
of enzyme activity was deﬁned as 1 nmol product generated
per min.
Nucleotide incorporation assay
Nucleotide incorporation assays were performed by growing
Borrelia strains in 100 ml of BSKII containing 20 mCi (1 nmol)
of tritium [
3H]-labelled ribonucleoside-5′-monophosphates or
deoxyribonucleoside-5′-monophosphates (Moravek, Brea,
CA) to a density of ~8 ¥ 10
7 cells ml
-1. The cells were har-
vested by centrifugation (8000 g, 15 min at 4°C), washed 3¥
in HS buffer (50 mM NaCl in 10 mM HEPES, pH 7.4) and
nucleic acids were isolated using Qiagen RNA/DNA Maxi Kit
(Valencia, CA) per the manufacturer’s instructions. The purity
of RNA and DNA samples was veriﬁed by agarose gel elec-
trophoresis and A260/280. Incorporation of labelled nucleotide
was assayed by scintillation counts and normalized to the
concentration of the nucleic acid. In addition, purity of each
sample was conﬁrmed by treating the RNA or DNA samples
with DNase or RNase respectively, and repeating scintillation
analysis.
DNA digestion and HPLC analysis
DNA samples, prepared as described above, containing
[
3H]-labelled nucleotides were analysed to determine the fate
of the radiolabel tag and nucleotide composition. A 50 ml
aliquot of the DNA preparation was denatured (97°C for
2 min) and then immediately placed on ice. Ten microliters of
0.3M NaOAc pH 5.3, 5 ml 20 mM ZnSO4 and 10 mlP 1
Nuclease (Sigma-Aldrich) were added to each sample and
incubated at 37°C for 2 h. Next, 10 mlo f1 0 ¥ Antarctic phos-
phatase buffer and 2 ml (10 units) of Antarctic phosphatase
(NEB, Ipswich, MA) were added and incubated at 37°C for
20 h. The reaction mixture was analysed by HPLC under the
following conditions: 75 ml aliquot of sample was injected onto
a Supelcosil LC-18-S 4.6 mm ¥ 150 mm, 5 mm analytical
column (Supelco) equilibrated with 50 mM potassium phos-
phate, pH 4.5, containing 8% methanol. Compounds were
eluted from the column isocratically for 20 min at 1 ml min
-1,
monitoring absorbance at 254 nm. Furthermore, spectral
data were collected for each peak using a diode array detec-
tor scanning from 200 to 600 nm. Peaks were identiﬁed by
matching retention time with that of an authentic deoxy-
nucleoside standard (dAdo, dC, dI, dGuo or dT), and further
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scans. If labelled DNA was used, fractions were collected
corresponding to each eluted peak, utilizing an automated
fraction collector, and the presence of radioactivity quantiﬁed
in each peak fraction using a scintillation counter.
IMP dehydrogenase assay (GuaB)
Recombinant IMP dehydrogenase (obtained from Dr Lizbeth
Hedstrom, Brandeis University) was assayed as described by
Zhou et al. (1997). Brieﬂy, the reaction mixture contained
50 mM Tris buffer at pH 8.0, 100 mM KCl, 1 mM DTT, 1 mM
NAD, 0.1 mM substrate and 0.002 mM puriﬁed enzyme
(~95% purity). All components (minus substrate) were incu-
bated at 25°C at A340. Once UV absorbance stabilized, sub-
strate (IMP, dIMP or dI) was added and the reaction mixture
was monitored at A340 for 10 min.
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